Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104892672B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104892672B details a novel chiral spiro phosphine-nitrogen-sulfur ligand enabling high-efficiency asymmetric hydrogenation for cost-effective pharmaceutical intermediate manufacturing.